ISDA

Deposition Date 2009-10-07

Release Date 2010-03-02

Last Version Date 2024-10-30

Entry Detail

PDB ID:

3K5C

Keywords:

HYDROLASE/HYDROLASE INHIBITOR

Title:

Human BACE-1 complex with NB-216

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.12 Å

R-Value Free:

0.22

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Beta-secretase 1
Gene (Uniprot):BACE1
Chain IDs:A, B, C
Chain Length:402
Number of Molecules:3
Biological Source:Homo sapiens

UniProt ID:P56817 Pfam ID:PF00026 EC:3.4.23.46

Ligand Molecules

0BI

Primary Citation

Macrocyclic BACE-1 inhibitors acutely reduce Abeta in brain after po application.

Lerchner, A, Machauer, R, Betschart, C, Veenstra, S, Rueeger, H, McCarthy, C, Tintelnot-Blomley, M, Jaton, A.L, Rabe, S, Desrayaud, S, Enz, A, Staufenbiel, M, Paganetti, P, Rondeau, J.M, Neumann, U, Machauer, R, Laumen, K, Veenstra, S, Rondeau, J.-M, Tintelnot-Blomley, M, Betschart, C, Jaton, A.-L, Desrayaud, S, Staufenbiel, M, Rabe, S, Paganetti, P, Neumann, U.Show

Bioorg.Med.Chem.Lett. 20 603 607 (2010)

PMID: 19963375 DOI: 10.1016/j.bmcl.2009.11.092

Abstact

A series of macrocyclic peptidic BACE-1 inhibitors was designed. While potency on BACE-1 was rather high, the first set of compounds showed poor brain permeation and high efflux in the MDRI-MDCK assay. The replacement of the secondary benzylamino group with a phenylcyclopropylamino group maintained potency on BACE-1, while P-glycoprotein-mediated efflux was significantly reduced and brain permeation improved. Several compounds from this series demonstrated acute reduction of Abeta in human APP-wildtype transgenic (APP51/16) mice after oral administration.

Legend

Protein

Chemical

Disease

Primary Citation of related structures